Literature DB >> 10734102

Allosteric activation of acid alpha-glucosidase by the human papillomavirus E7 protein.

W Zwerschke1, B Mannhardt, P Massimi, S Nauenburg, D Pim, W Nickel, L Banks, A J Reuser, P Jansen-Dürr.   

Abstract

Changes in the cellular carbohydrate metabolism are a hallmark of malignant transformation and represent one of the earliest discernible events in tumorigenesis. In the early stages of certain epithelial cancers, a metabolic switch is regularly observed, in which slowly growing glycogenotic cells are converted to highly proliferating basophilic cells. This step is accompanied by a rapid depletion of the intracellular glycogen stores, which in liver carcinogenesis results from the activation of the enzyme acid alpha-glucosidase by an as yet unknown mechanism. We show here that acid alpha-glucosidase is a target for the E7 protein encoded by human papillomavirus type 16, a human tumor virus that plays a key role in the genesis of cervical carcinoma. We show that expression of E7 induces the catalytic activity of acid alpha-glucosidase in vivo and wild type E7, but not transformation-deficient mutants bind directly to acid alpha-glucosidase and increase the catalytic activity of the enzyme in vitro. The data suggest that the E7 protein encoded by human papillomavirus type 16 can act as an allosteric activator of acid alpha-glucosidase.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10734102     DOI: 10.1074/jbc.275.13.9534

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.

Authors:  A M Helt; D A Galloway
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3.

Authors:  B Mannhardt; S A Weinzimer; M Wagner; M Fiedler; P Cohen; P Jansen-Dürr; W Zwerschke
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

Review 3.  Molecular interactions of 'high risk' human papillomaviruses E6 and E7 oncoproteins: implications for tumour progression.

Authors:  Oishee Chakrabarti; Sudhir Krishna
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

4.  USP11 stabilizes HPV-16E7 and further modulates the E7 biological activity.

Authors:  Ching-Hui Lin; Hung-Shu Chang; Winston C Y Yu
Journal:  J Biol Chem       Date:  2008-04-11       Impact factor: 5.157

5.  Critical roles for non-pRb targets of human papillomavirus type 16 E7 in cervical carcinogenesis.

Authors:  Scott Balsitis; Fred Dick; Nicholas Dyson; Paul F Lambert
Journal:  Cancer Res       Date:  2006-10-01       Impact factor: 12.701

6.  Interference with energy metabolism by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside induces HPV suppression in cervical carcinoma cells and apoptosis in the absence of LKB1.

Authors:  Julia Nafz; Johanna De-Castro Arce; Verena Fleig; Andrea Patzelt; Sybille Mazurek; Frank Rösl
Journal:  Biochem J       Date:  2007-05-01       Impact factor: 3.857

7.  Transglutaminase 2 inhibits Rb binding of human papillomavirus E7 by incorporating polyamine.

Authors:  Ju-Hong Jeon; Kyung-Ho Choi; Sung-Yup Cho; Chai-Wan Kim; Dong-Myung Shin; Joon-Cheol Kwon; Kye-Yong Song; Sang-Chul Park; In-Gyu Kim
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

8.  Examination of the pRb-dependent and pRb-independent functions of E7 in vivo.

Authors:  Scott Balsitis; Fred Dick; Denis Lee; Linda Farrell; R Katherine Hyde; Anne E Griep; Nicholas Dyson; Paul F Lambert
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  The papillomavirus E7 oncoprotein is ubiquitinated by UbcH7 and Cullin 1- and Skp2-containing E3 ligase.

Authors:  Kwang-Jin Oh; Anna Kalinina; Jing Wang; Keiko Nakayama; Keiichi I Nakayama; Srilata Bagchi
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Biomarkers in cervical cancer.

Authors:  Eun-Kyoung Yim; Jong-Sup Park
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.